Skip Navigation

Eligible for a Baby Formula lawsuit?

Enfamil Similac NEC Lawsuit

Enfamil Similac NEC Lawsuit

Enfamil and Similac Baby Formula Lawsuit

UPDATES AND NEC SETTLEMENT INFORMATION

What is the NEC Lawsuit About?

Families of premature infants diagnosed with necrotizing enterocolitis (NEC) caused by Similac or Enfamil baby formula are pursuing lawsuits against the manufacturers.

As a result of a failure to warn families and medical providers about the risks associated with use of cow’s milk formula with preemies, financial compensation and NEC settlement benefits may be available by filing a baby formula lawsuit.

Lawsuits are being pursued for children who meet the following criteria:

  • Born after January 1, 2000;
  • Premature at 34 Weeks Gestation of Less
  • Fed Similac or Enfamil Formula or Fortifier; and
  • Diagnosed with NEC (necrotizing enterocolitis) or passed away due to sudden gastrointestinal issues.

UPDATED:


  • Similac Lawsuits and Enfamil Lawsuits are being pursued by families nationwide
  • Studies establish an increased risk of necrotizing enterocolitis (NEC) from Similac or Enfamil given to premature babies, compared to breast milk or other cow’s milk formula given to preemies, compared to breast milk
  • Despite known risks, Similac and Enfamil baby formula were marketed for use among preemies in the NICU or hospital
  • CONTACT A NEC BABY FORMULA LAWYER TO MAKE A CLAIM

Enfamil and Similac NEC Lawsuit Overview

Similac and Enfamil are two popular types of infant formula that have been marketed as safe and effective for premature babies. As a result, the baby formula is often fed to preemies or low birth weight infants in the NICU or hospital before discharge. However, cow’s milk-based products like Enfamil and Similac have been linked to necrotizing enterocolitis (NEC) among premature infants, which can result in serious injuries, lifelong health complications and death.

A number of studies published over the past three decades have highlighted the link between NEC and Similac, Enfamil or other cow’s milk formula fed to premature infants. However, false and misleading information has been provided to parents, hospitals and medical providers about the risks associated with baby formula and the benefits of breast milk.

Families are now pursuing Enfamil and Similac lawsuits in state and federal courts nationwide, alleging that the manufacturers placed their desire for profits before consumer safety.

Who Can File an Infant Formula NEC Lawsuit?

Enfamil NEC Lawsuits

Parents of infants who developed NEC are filing Enfamil NEC lawsuits against Mead Johnson Nutrition Company after consuming the following Enfamil products;

  • Enfamil NeoPro EnfaCare Infant Formula
  • Enfamil Premature Infant Formula 24 Cal High Protein
  • Enfamil Premature Infant Formula 30 Cal with Iron
  • Enfamil Premature Infant Formula 24 Cal with Iron
  • Enfamil Premature Infant Formula 20 Cal with Iron
  • Enfamil 24 Cal Infant Formula
  • Enfamil Human Milk Fortifier (acidified liquid and powder)

Similac NEC Lawsuits

Parents of infants who developed NEC are filing Similac NEC lawsuits against Abbott Laboratories after consuming the following Similac products;

  • Similac NeoSure
  • Similac Special Care 20
  • Similac Special Care 24
  • Similac Special Care 24 High Protein
  • Similac Special Care 30
  • Similac Alimentum Expert Care
  • Similac Human Milk Fortifier (which is actually a cow’s milk product)
  • Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid
  • Similac Liquid Protein Fortifier

Free consultations and claim evaluations are provided to help determine if a family may be eligible for a baby formula NEC settlement, and there are no fees or expenses unless a recovery is obtained.

Enfamil Similac NEC Lawsuit
Enfamil Similac NEC Lawsuit

2025 Similac and Enfamil NEC Lawsuit Updates: MDL 3026

All Similac lawsuits and Enfamil lawsuits over NEC have been centralized as part of an MDL before U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois since April 2022, where parties are preparing a small group of representative claims for early trial dates. While the outcomes of these “bellwether” trials will not be binding on other families, the average NEC lawsuit payout amount may influence the amount of any settlement offers Abbott or Mead Johnson may offer to resolve claims in the future.

  • July 9, 2025 Update: U.S. District Judge Rebecca Pallmeyer has ruled that Mead Johnson must face an NEC lawsuit in Missouri state court, rejecting the company’s attempt to remove the case to the federal MDL. The lawsuit, filed by an Illinois mother over her child’s NEC diagnosis after being fed Enfamil, was originally brought in St. Louis Circuit Court. While most claims remain consolidated in the federal court system, with 744 lawsuits currently pending, the ruling means this case will proceed separately in Missouri state court.
  • June 24, 2025 Update: Opening arguments in the first federal NEC formula bellwether trial are scheduled to begin August 8, 2025, involving a Maryland child who suffered lifelong injuries after being fed Similac and Enfamil. The outcome of this trial may heavily influence future settlement negotiations, as manufacturers face more than 700 similar claims nationwide.
  • June 2, 2025 Update: Following the dismissal of the first NEC bellwether trial, lawyers will meet with the MDL judge on June 11 to discuss next steps in the litigation. The lawsuit was dismissed due to facts unique to that case and is not expected to affect the broader claims. A second bellwether trial remains scheduled for August 11, 2025. There are currently 740 Similac and Enfamil NEC lawsuits pending in the MDL.
  • May 6, 2025 Update: The first baby formula NEC bellwether trial was dismissed after the court found insufficient evidence in the individual case to support claims that Similac caused the infant’s death. However, in a major win for plaintiffs, Judge Pallmeyer denied motions to exclude expert witnesses who link cow’s milk-based formula to NEC, allowing the science behind the claims to be presented in upcoming trials. With the next bellwether scheduled for August 11, the litigation remains on track, and jury outcomes are expected to heavily influence potential Similac and Enfamil NEC settlement talks.
  • May 1, 2025 Update: As new Enfamil and Similac NEC lawsuits continue to be filed by parents of children who have suffered severe gastrointestinal injuries caused by the manufacturers failure to warn about NEC risks, the JPML reports there were an additional 47 claims added to the litigation since March, marking a steady incline of new cases.
  • March 5, 2025 Update: The JPML has recently issued an updated docket, indicating there are now 663 baby formula lawsuits filed against the makers of Enfamil and Similar over their alleged failure to warn about NEC side effects.
  • January 14, 2025 Update: As the NEC lawsuit bellwether trials approach in the coordinated proceedings, Judge Pallmeyer has reappointed the group of 32 attorneys previously selected to lead the litigation. According to a case management order issued on January 13, these attorneys will continue handling key pretrial tasks, such as arguing motions, conducting depositions, and managing discovery on behalf of all plaintiffs. Their ongoing leadership aims to streamline the process and ensure consistent representation of common issues across the cases.
  • November 1, 2024: In the third trial of its kind, a Missouri jury has exonerated the manufacturers of Similac and Enfamil, finding Abbott Laboratories and Mead Johnson not liable for a newborn’s development of necrotizing enterocolitis (NEC), despite previous cases ending in over $555 million in judgments against them. The decision came after a closely watched five-week trial involving a lawsuit brought by Elizabeth Whitfield
  • October 14, 2024 Update: The parties submitted a stipulation regarding proposed trial dates indicating that the first federal Baby formula NEC lawsuit, filed by plaintiff Erica Mar, will be ready to go before a jury on May 5, 2025. The second bellwether trial, involving claims by Keosha Diggs, is slated for trial starting on August 11, 2025, followed by a trial starting on November 3, 2025, and a fourth bellwether trial to be held on February 2, 2026.
  • October 4, 2024 Update: Following two baby formula NEC jury awards that ordered the manufacturers to pay more than $555 million in combined compensation to families, the latest baby formula trial involving Abbott Laboratories, Mead Johnson, and St. Louis Children’s Hospital began on Monday, focusing on allegations that they failed to warn Elizabeth Whitfield (plaintiff) about the risks of NEC associated with cow’s milk-based infant formulas. Whitfield’s premature son, born in August 2017 at less than 28 weeks gestation, developed NEC after being fed Similac and Enfamil, leading to surgery to remove part of his intestines. The manufacturers dispute the claims, citing a lack of scientific evidence, despite existing studies that highlight increased NEC risks from cow’s milk products and recommend breast milk as a safer alternative. This trial is drawing significant attention, especially with several federal bellwether trials in preparation.
  • September 26, 2024 Update: According to a docket entry from Judge Pallmeyer, the schedule for the initial bellwether trials in the baby formula NEC lawsuits has been set. The first two trials will address cases filed against Abbott Laboratories. The third trial will involve a case against both Abbott Laboratories and Mead Johnson. The fourth will focus exclusively on a lawsuit against Mead Johnson, the manufacturer of Enfamil.
  • September 20, 2024 Update: An adult woman has filed a Similac NEC lawsuit indicating that she received Similac shortly after birth, and subsequently developed NEC while still in the hospital. As a result of the NEC injuries, she required multiple surgeries as an infant and indicates that she has been left with severe, long-term health effects, which continue to require ongoing medical care 18 years later, even as she enters adulthood.
  • August 1, 2024 Update: A St. Louis jury issued a Similac NEC lawsuit award, ordering Abbott Laboratories to pay $95 million in compensatory damages to an Illinois mother for failing to warn about the risk of NEC from Similac, with another $400 million assessed to punish the manufacturer for it’s conduct.
  • July 24, 2024 Update: In a Bloomberg News report issued on July 18, Abbott Laboratories CEO Robert Ford reportedly told investors that the company is considering removing Similac Special Care and other premature infant formulations from the market, amid increasing concerns about the risk of necrotizing enterocolitis (NEC), and legal liability the company faces for failing to warn about the increased risks preemies face of developing the devastating gastrointestinal condition from cow’s milk-based formula.
  • June 25, 2024 Update: In a court order issued this month, Judge Pallmeyer has given the parties more time to finish fact discovery for a series of “bellwether” claims, extending the close of fact discovery deadline to August 9, while also laying out a schedule for the first NEC baby formula lawsuit trials to begin in May, 2025. The updated schedule calls for the parties to conduct expert depositions from November 4, 2024 through January 10, 2025, with all motions for summary judgment and Daubert challenges to the admissibility of expert testimony due by January 24, 2025. The Court will then hold Daubert hearings on March 24, 2025, at which time Judge Pallmeyer will determine whether the expert witness testimony proposed by each side involves opinions that are sufficiently reliable and sound for a jury to consider.
  • June 17, 2024 Update: In one of the most recent Enfamil NEC lawsuits filed in the Baby Formula MDL, Tanika Graham, of California, filed a lawsuit raising allegations that Mead Johnson intentionally exploits vulnerable families for financial gain, by withholding critical information about the link between Enfamil and NEC for premature infants. Graham’s complaint joins hundreds of similar lawsuits pending in the litigation, each raising similar allegations that children developed necrotizing enterocolitis (NEC) after being fed the cow’s milk-based formula.
  • May 14, 2024 Update: U.S. District Judge Rebecca R. Pallmeyer issued a case management order on May 6, mandating that plaintiffs’ lawyers confirm that infants were given Mead Johnson’s (Enfamil) products by performing a detailed review of medical and feeding records before naming the company in a lawsuit. Non-compliance with these stringent verification protocols may lead to the dismissal of cases lacking sufficient evidence of product usage.
  • April 7, 2024 Update: Following a groundbreaking $60 million Enfamil NEC lawsuit verdict, 50 new infant formula NEC lawsuits were filed in the multi district litigation last month. The U.S. JPML announced there are now 453 infant formula NEC lawsuits pending in the Preterm Infant Nutrition Products Liability Litigation.
  • March 15, 2024 Update: A jury in Illinois state court awarded a $60 million verdict in an Enfamil NEC lawsuit, directing Mead Johnson to compensate the mother of a premature infant who died of necrotizing enterocolitis (NEC) after being fed Enfamil formula shortly after birth.
  • March 3, 2024 Update: U.S. District Judge Rebecca R. Pallmeyer has given the parties until June 28, 2024, to complete general fact discovery for a group of 12 NEC lawsuits selected for early trial dates, providing an extension of two months over the original timeline.
  • October 5, 2023 Update: Judge Pallmeyer has ordered a series baby formula NEC settlement talks be held this month in an effort to explore a resolution for hundreds of similar claims being pursued by families nationwide before the first bellwether trials begin.
  • June 30, 2023 Update: Judge Pallmeyer dismissed all of the infant formula NEC class action lawsuits, allowing the individual claims to proceed. Shortly following, the parties submitted a joint plan to select 10 potential baby formula NEC lawsuits for the first bellwether trials. Nine of those cases were chosen to proceed by Judge Pallmeyer in early November 2023.
  • April 24, 2023 Update: The parties agreed on a series of discovery protocols that will help prepare the bellwether NEC lawsuits for early trial dates.
  • November 2022 Update: Plaintiffs proposed an infant formula NEC bellwether trial schedule which would see the first case go before a jury in mid-2024.
  • October 2022 Update: Parties have submitted a list of 66 claims which could serve as potential NEC baby formula bellwether trials. That list will be whittled down to four cases which will serve as the first early test cases.
  • September 2022 Update: U.S. District Judge Rebecca R. Pallmeyer appointed a group of 12 lawyers to serve in various leadership positions during the multidistrict litigation (MDL) proceedings.
  • April 2022 Update: The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order (PDF) on April 8, 2022, establishing a Infant Formula NEC MDL 3026 for the growing number of NEC lawsuits over Similac and Enfamil. The order transferred all claims filed throughout various federal courts to U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois. Judge Pallmeyer is expected to call for a series of early “bellwether” trials designed to help gauge how juries are likely to respond to certain evidence that will be repeated throughout the litigation.
  • August 2021 Update: A federal judge rejected an attempt by Abbott Laboratories to entirely dismiss a wrongful death lawsuit filed, certifying two questions to the Connecticut state Supreme Court that are relevant to the claims for failure to warn about the link between Similac and NEC.
  • May 2021 Update: One of the earliest Similac necrotizing enterocolitis lawsuits was filed in May 2021, by the parents of a premature baby born in April 2019, who died only 16 days later. The lawsuit alleges that Similac caused NEC, and that the manufacturer failed to adequately warn about the risk.

Enfamil and Similac NEC Risks

Necrotizing enterocolitis (NEC) is a serious health condition that may be caused by toxic baby formula, where an infant’s intestinal tissues becomes inflamed. If left untreated, it can cause that tissue to die, resulting in perforations in the intestines, which allow bacteria to leak into the abdomen or infiltrate the bloodstream. This can lead to life-threatening infections, narrowing of the intestines, short bowel syndrome, developmental delays and a failure to thrive.

About 90% of NEC cases occur among babies born in the 37th week of pregnancy and about 1 out of every 1,000 premature infants may be effected. It is usually diagnosed through a blood test for bacterial infections, fecal tests looking for blood in the stool, or by x-rays revealing air bubbles in the abdomen or around the intestines.

Symptoms can include:

  • Abdominal pain
  • Abdominal swelling
  • Changes in heart rate, blood pressure, breathing and temperature
  • Bloody diarrhea
  • Green or yellow vomit
  • Inability to gain weight
  • Lack of appetite
  • Lethargy

Although numerous studies published in recent years have linked Similac and Enfamil to an increased risk of NEC, the manufacturers have failed to provide adequate warnings about the potential risk to infants, and in fact still promote their products as a preferred, premium formula for premature infants.

Some studies have indicated babies fed cow’s milk formula exclusively are six to 10 times more likely to be diagnosed with NEC than infants given only breast milk.


Studies Linking Cow’s Milk Formula to NEC and Supporting Breastfeeding for Preemies

Years of research have consistently shown that cow’s milk-based infant formulas like Similac and Enfamil significantly increase the risk of necrotizing enterocolitis (NEC) among premature infants, compared to human breast milk. The studies below highlight the protective role of breast milk, the dangers associated with formula feeding in preemies, and the growing medical consensus that exclusive human milk diets should be the standard of care in NICUs.

Human Milk Diet Cuts NEC Risk and Mortality in Preemies, Study Confirms

In a study published in Advances in Neonatal Care on February 13, 2025, researchers from Memorial Hospital in Savannah and Troy University in Alabama compared the outcomes of extremely premature infants fed either an exclusive human milk diet (EHMD) or cow’s milk-based formula such as Similac and Enfamil. The study found that infants given bovine-based formulas were more than twice as likely to develop NEC and six times more likely to die in infancy than those fed human milk.

The trial evaluated 201 infants born before 32 weeks gestation and weighing less than 1,250 grams. Among those fed Similac or Enfamil formula, 10.5% developed NEC, compared to only 4.8% of infants given breast milk. Additionally, the mortality rate was 6% in the formula group, while it was only 1% in the human milk group.

The human milk-fed infants also gained weight more effectively, suggesting stronger overall health outcomes. The study’s authors urged NICUs to adopt exclusive human milk diets as standard practice, further highlighting how formula companies have downplayed the known dangers of cow’s milk products for this vulnerable population.

Mother’s Milk Contains Bioactive Nutrients That Protect Against NEC

In a study published in Nutrients on October 28, 2021, researchers from Washington University School of Medicine analyzed breast milk samples from mothers of preterm infants to assess how different components of human milk influenced NEC risk.

They found that key nutrients such as lipids and fatty acids played a role in neonatal growth and gut development, factors critical to preventing necrotizing enterocolitis (NEC). The study reinforced prior findings that human milk offers a protective advantage over cow’s milk-based formula in premature infants.

The research team studied samples collected in a NICU setting from mothers whose babies either did or did not develop NEC, and confirmed that while individual milk composition varied, breast milk consistently provided antimicrobial and bioactive compounds essential for infant health. These compounds help regulate intestinal function and immune response—benefits not replicated in formulas like Similac and Enfamil. The authors concluded that human milk is the “gold standard” for preterm nutrition, and its absence leaves infants vulnerable to diseases like NEC, particularly when substituted with formula aggressively promoted for NICU use.

Meta-Analysis Identifies Breastfeeding as Key Protective Factor Against NEC

In a study published in BMC Pediatrics on March 22, 2024, Chinese researchers conducted a comprehensive meta-analysis of 8,616 premature infant NEC cases, identifying breastfeeding as one of the most effective protective measures against the condition.

While 16 factors were found to increase NEC risk, including respiratory failure, infections, congenital heart disease, and blood transfusions, the researchers concluded that breast milk, oral probiotics, and prenatal glucocorticoids significantly reduced the risk of NEC, with breastfeeding lowering it by roughly one-third.

The study emphasized that breast milk provides a biological defense system not present in cow’s milk-based formulas like Similac and Enfamil. Specifically, it contains secretory IgA, lactoferrin, and other antimicrobial substances that help protect the gut lining from harmful bacteria.

The researchers noted that breast milk’s lower osmolality also helps reduce intestinal stress in premature infants. In contrast, cow’s milk formula can increase osmotic load and bacterial imbalance that can contribute to NEC development. These findings add further weight to allegations that formula manufacturers ignored known protective science in favor of aggressive product promotion in neonatal care units.

Breastfeeding Linked to Lower Risk of Developmental Delays in Infants

In a study published in JAMA Network Open on March 24, 2025, researchers analyzed the developmental outcomes of over 500,000 children born in Israel between 2014 and 2020. The study found that infants who were breastfed for at least six months were significantly less likely to experience delays in achieving language, motor, and social milestones compared to infants breastfed for shorter periods or not at all. The data showed that breastfeeding for six months reduced the likelihood of developmental delays by more than 25%.

Importantly, the researchers also compared sibling pairs, where one child was breastfed and the other was not, and found consistent results: the breastfed child was less likely to develop neurodevelopmental conditions. These findings reinforce the idea that breast milk provides essential nutrients and protective factors that are not replicated in cow’s milk-based infant formula products like Similac and Enfamil. While manufacturers have promoted their formulas as safe and nutritionally complete, this and other research demonstrates that they are inferior substitutes, especially for vulnerable infants during critical developmental periods.


Similac & Enfamil NEC Settlements

As of March 2024, there have been no global settlements in the Enfamil and Similac NEC lawsuits currently pending in the federal court system, where the claims have been consolidated before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois.

In 2023, Judge Pallmeyer ordered the parties to select four infant formula NEC lawsuits for an initial bellwether trial pool, to serve as early test cases to see how juries will respond to common evidence and arguments likely to be repeated in hundreds of similar claims.

While the date the first NEC bellwether trial in the federal court system not yet been scheduled, Judge Pallmeyer has previously indicated the cases will be spaced about 12 weeks apart, and prior scheduling orders suggested the claims would be ready to go before juries by the end of 2024.

Bellwether trials serve a strategic purpose in mass tort litigation by providing a sample of jury responses to evidence and arguments that are common across a large number of similar cases. The outcomes of these Enfamil and Similac NEC trials can significantly influence the course of the litigation for several reasons, potentially encouraging a global settlement offer.

How much is an infant formula NEC lawsuit worth?

In March 2024, the first Enfamil NEC lawsuit to go before trial resulted in an Illinois jury awarding $60 million in damages to the mother of a premature infant who died of necrotizing enterocolitis (NEC) after being fed Enfamil formula shortly after birth.

Although the case was filed in an Illinois state court and not included in the MDL, the lawsuit was being closely watched, since it was the first Enfamil NEC lawsuit to go to trial in the United States, and may signal how juries will respond to similar evidence and testimony during the upcoming Enfamil and Similac NEC bellwether trials.


Free Similac or Enfamil Lawsuit Evaluation

NEC lawyers provide free consultations and claim evaluations to help determine if financial compensation and settlement benefits may be available as a result of the manufacturers’ failure to warn about the link between Similac, Enfamil and necrotizing enterocolitis.

Toxic baby formula Lawsuits are being investigated nationwide for parents of infants who were left severely injured, or who died, due to an NEC diagnosis after being fed Similac or Enfamil while hospitalized.

ENFAMIL OR SIMILAC NEC LAWYERS

All claims are handled on a contingency fee basis and there are no out-of-pocket expenses and no fees unless a recovery is obtained.

Citations and References

At AboutLawsuits.com, we are committed to providing trustworthy legal news supported by credible, authoritative sources. Our reporting is based on government safety warnings, peer-reviewed medical research, and official court records to ensure readers have access to accurate and verifiable information. The following external references were used throughout this page to support key facts and findings.

  1. Disparities in Necrotizing Enterocolitis Incidence Among Black and White Preterm Infants in the US
    JAMA Network Open, April 2025
    https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2831869
  2. Exclusive Human Milk Diets and the Reduction of Necrotizing Enterocolitis in Preterm Infants
    Advances in Neonatal Care, October 2024
    https://journals.lww.com/advancesinneonatalcare/abstract/2024/10000/exclusive_human_milk_diets_and_the_reduction_of.4.aspx
  3. Bovine-Based Fortifiers and Risk of Necrotizing Enterocolitis in Premature Infants
    Nutrients, October 2021
    https://www.mdpi.com/2072-6643/13/10/3604
  4. Feeding Type and NEC Risk in Preterm Infants: A Multicenter Cohort Study
    BMC Pediatrics, April 2024
    https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-024-04607-3
  5. Enfamil Baby Formula NEC Lawsuit Information & Eligibility
    YouHaveALawyer.com
    https://www.youhavealawyer.com/baby-formula-nec-lawsuit/enfamil-lawsuit/
  6. Similac Baby Formula NEC Lawsuit Information & Eligibility
    YouHaveALawyer.com
    https://www.youhavealawyer.com/baby-formula-nec-lawsuit/similac-lawsuit/
  7. Initial Transfer Order Establishing NEC Baby Formula Litigation MDL
    U.S. Judicial Panel on Multidistrict Litigation, March 2022
    https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3026-Initial-Transfer-Order-3-22.pdf
  8. Reckitt Unit Hit With $60 Million Verdict in Enfamil Baby Formula Case
    Reuters, March 14, 2024
    https://www.reuters.com/legal/reckitt-unit-hit-with-60-million-verdict-enfamil-baby-formula-case-illinois-2024-03-14/
  9. Abbott Ordered to Pay $495 Million in Baby Formula NEC Verdict
    The Wall Street Journal, March 2024
    https://www.wsj.com/business/abbott-ordered-to-pay-495-million-in-baby-formula-verdict-77cbe331
  10. Necrotizing Enterocolitis (NEC): Overview and Symptoms
    Cleveland Clinic
    https://my.clevelandclinic.org/health/diseases/10026-necrotizing-enterocolitis
  11. Necrotizing Enterocolitis: Clinical Features, Diagnosis, and Treatment
    StatPearls Publishing, Updated 2024
    https://www.ncbi.nlm.nih.gov/books/NBK513357/
  12. Necrotizing Enterocolitis: Pathophysiology, Clinical Presentation, and Prevention Strategies
    Frontiers in Pediatrics, November 2019
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6918740/

19 Comments


Andrea
If Enfamil and simulation is for preemies then why was my son give it? He wasn’t a premier. What the????

KEMIA
Both of My Daughters 1 born in 1997 and other in 2000,Similac and Enfamil. They had real issues with digesting there food as they grew older. Realizes they became latoose intolerant. They .when they were under the age of 5. Both of them would complain of stomach pains with constipation and at times diarrhea. The oldest girl would run to bathroom after eating all the time.she seems to. E always under weight when doing check ups both of them.shes now 25 she’s 5’2 and weight is 108 pounds. She wares petite clothes. 2nd Daughter is 21 yrs old 5’1′ she weighs like 105. This after having 2 babies . The eating habits now are haywire. They are both iron deficit and now Anemic. Just like Me there Mom… hmmmm wondering what Milk u was drinking in the 1980 growing up in California.

Ingrid
Orion my 4th child born in 2013 10 months after his brother he cryed for ten months never seemed comfortable and never enjoyed his days I became postpartum due to not being to comfort him he stayed swollen in the stomach region and Dr summed it up to gas and acid reflux issues even when given the meds he still cryed… He cryed so often I called him crying Orion. Ten months into his life I decided to indefinitely take him off of the numourous formula he switched threw it wasn’t long 3 days nd Orion stopped crying he had a personality we finally got to see and he took off after this he finally got to play crawl and not long took to taking steps before this Orion just cryed and slept it was definitely no life for baby to be placed in such an uncomfortable position

Stephanie
I have 5 children, and the first 3 who are now 10, 8, and 3, all have stomach issues. They throw up constantly for no reason. My last 2 are twins born in Oct 2020, one of them seems to not be growing as he should. I am very upset to hear about this because my children have suffered for years, and if it’s because of the formula I was told to give them, then that’s horrible!! How can these companies be so evil!!!???

Heather
I wonder what ages or years because both my boys were born in the mid 90’s they have the worse stomach issues that I’ve ever heard of or seen. My 1st born is worse actually because ever since the day he was born he had such a hard time after giving Similac and Infamil.

Heather
I wonder what ages or years because both my boys were born in the mid 90’s they have the worse stomach issues that I’ve ever heard of or seen. My 1st born is worse actually because ever since the day he was born he had such a hard time after giving Similac and Infamil.

Tiffiney
My son expired from NEC. How could a 5 week old bare that much pain and trauma. I blamed myself for years, maybe I should have pulled the cord, maybe I should have stayed with him that night a little longer. My son was due to come home in a couple weeks. The next time I saw him, when they called me to the NICU, he was so swollen, I was afraid to touch him because I thought he would burst open. All the tubes, and the surgery, removing a large portion of his intestines. I have to stop myself from thinking about it because it hurts, and I felt powerless. I hurt for my little baby. Trying to be so strong. NOONE should have to go through so much pain.

Lourdes
I wonder how long they can check on the gut damage that caused by taking similac baby milk ? 3 among the family children was taken same baby formula and now grown adults but suffering from gut issues such acidity flare ups and constipation and occasionally vomiting. One of those kids is my own daughter and kinda worried and make me think that it might be associate to the milk she take when she was a baby. At times it was the most expensive and highly recommend baby formula. Being a single Mom, I struggle to get the best for y daughter but I have to do it since that’s the only formula that was best recommend by the pediatrician.

Ronda
My baby was born November 14, 2006 and they told us several time that we couldn’t hold him for several days but come to find out they told me that he had a hole in the inestines and that they needed to do a emergency surgery because of the hole in his stomach and that they needed to remove the damage intestine and try to treat infection but it was to late my son got the surgery and he didnt make it because of the infection that was in his stomach.

Shaima
Need answer

Tina
I am so sorry for all the grief and loss here. The NICU refused to give my preemie formula and pushed donor milk for this exact reason. I believe somewhere in small print it says not for preemies on the cans. Answers are needed, tragic!

Eugene
In 2004 my son was born 1 pound 13 ounces he was in NICU for 4 months during this time he was given enfamil and was diagnosed with NEC he had to have 6 inches of his intestines removed ( because it died ) he went through multiple surgeries the result was devastating he is 17 now and is still having issues.

Stephanie
We lost our first due to NEC in 2006. He was born at 31 weeks and lived for 31days. The doctors and nurses kept blaming all his symptoms on him being a preemie and I asked for xrays of his stomach but I was told there wasn’t any need.

Kaprice
Need answers

Barbara
My Dougher was on Enfamil and she got bed alerge for whole life and lot of health isue

Valkyrie
I almost lost my 4 month old son, due to a certain kind of enfamil.

Nellie
My twins were born at 37 weeks, they have been in formula from 3 months – 18 months They both had eczema from age 6 months – 3 years. Now they both are allergic to nuts. I believe so it’s due to formula Similac and Enfamil. I’m currently working on fixing their gut. I knew it’s all because of formula and I told that to my Dermatologist. Unfortunately besides steroid creams they didn’t offer anything else.

Jessica
what year?

Sergio
My son suffered from all of the symptoms and he passed away shortly after

Share Your Story With Our Community

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills.